Can a patient be tested for Clostridioides difficile (C. diff) in primary care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Patients Be Tested for C. difficile in Primary Care?

Yes, patients can and should be tested for C. difficile in primary care settings when they present with appropriate clinical symptoms, particularly given the increasing recognition of community-acquired C. difficile infection. 1

Evidence Supporting Primary Care Testing

Community-Acquired C. difficile is a Real Entity

  • A prospective study in The Netherlands demonstrated that when general practitioners submitted unformed stool samples for C. difficile testing, 1.5% were positive, with 65% of these patients having no healthcare facility admission in the prior year and 42% having no antibiotic use in the prior 6 months. 1

  • Community-acquired CDI occurs in patients without traditional risk factors in approximately 25-26% of cases, making it impossible to exclude based on patient characteristics alone. 1

  • Age range of community-acquired cases varied from 1 to 92 years, with 18% under age 20, demonstrating that CDI is not limited to elderly or hospitalized patients. 1

When to Test in Primary Care

Test patients with ≥3 unformed stools in 24 hours with no obvious alternative explanation (such as laxative use), particularly when common enteropathogens have been ruled out. 1, 2

Key clinical criteria include:

  • Diarrhea defined as three or more unformed stools in 24 hours 1, 3
  • No reasonable alternative cause for diarrhea 1
  • No laxative use within 24-48 hours 1
  • Clinical context such as recent antibiotic exposure, though its absence does not exclude CDI 1, 3

Testing Approach in Primary Care

Only test unformed stool samples, as testing formed stool results in false positives and unnecessary antibiotic therapy. 1, 3, 2

The recommended diagnostic approach involves:

  • Submit unformed stool samples to laboratories that use appropriate testing algorithms 1, 2
  • A two-step testing algorithm is preferred (such as GDH screening followed by toxin testing, or NAAT followed by toxin confirmation) to balance sensitivity and specificity 3, 2
  • Single toxin EIA testing alone is not recommended due to low sensitivity 1, 2

Important Caveats for Primary Care Providers

Avoid Common Pitfalls

  • Do not test asymptomatic patients or those with formed stools, even if they have risk factors or prior C. difficile history. 3, 4
  • Do not repeat testing within 7 days of a negative result during the same diarrheal episode unless there is strong ongoing clinical suspicion. 4
  • Understand that positive NAAT results may represent colonization rather than active infection, which is why multistep algorithms are preferred. 1, 3, 2

Clinical Context Matters

Interpret results in the context of:

  • Recent antibiotic administration (though not required for diagnosis) 1, 3
  • Fever, abdominal pain, and leukocytosis as markers of severity 1, 3
  • Elevated creatinine and serum lactate for assessing disease severity 1

Coordination with Laboratory

Ensure your laboratory uses appropriate testing methodology:

  • Multistep algorithms are superior to single tests 3, 2
  • NAAT alone may overdiagnose by detecting colonization 1, 3
  • Toxin EIA alone has insufficient sensitivity 1, 2

Bottom Line for Primary Care

Primary care providers should have a low threshold for testing patients with unexplained diarrhea for C. difficile, regardless of traditional risk factors, as community-acquired disease is increasingly common and cannot be predicted by patient characteristics alone. 1 The key is ensuring appropriate specimen selection (unformed stool only) and understanding that laboratory testing algorithms matter significantly for accurate diagnosis. 3, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approaches for Clostridioides difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

C. difficile Diagnostic Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for C. difficile in Neutropenic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.